Park JS - Search Results

1

Evaluation of generations 2, 3 and 4 arginine modified PAMAM dendrimers for gene delivery.

Nam HY, Hahn HJ, Nam K, Choi WH, Jeong Y, Kim DE, Park JS. Nam HY, et al. Among authors: park js. Int J Pharm. 2008 Nov 3;363(1-2):199-205. doi: 10.1016/j.ijpharm.2008.07.021. Epub 2008 Jul 30. Int J Pharm. 2008. PMID: 18718514

2

Biodegradable PAMAM ester for enhanced transfection efficiency with low cytotoxicity.

Nam HY, Nam K, Hahn HJ, Kim BH, Lim HJ, Kim HJ, Choi JS, Park JS. Nam HY, et al. Among authors: park js. Biomaterials. 2009 Feb;30(4):665-73. doi: 10.1016/j.biomaterials.2008.10.013. Epub 2008 Nov 8. Biomaterials. 2009. PMID: 18996585

3

Comparison between arginine conjugated PAMAM dendrimers with structural diversity for gene delivery systems.

Kim TI, Bai CZ, Nam K, Park JS. Kim TI, et al. Among authors: park js. J Control Release. 2009 Jun 5;136(2):132-9. doi: 10.1016/j.jconrel.2009.01.028. Epub 2009 Feb 11. J Control Release. 2009. PMID: 19331841

4

Effect of deoxycholate conjugation on stability of pDNA/polyamidoamine-diethylentriamine (PAM-DET) polyplex against ionic strength.

Jeong Y, Jin GW, Choi E, Jung JH, Park JS. Jeong Y, et al. Among authors: park js. Int J Pharm. 2011 Nov 28;420(2):366-70. doi: 10.1016/j.ijpharm.2011.08.048. Epub 2011 Sep 3. Int J Pharm. 2011. PMID: 21907775

5

Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma.

Bai CZ, Choi S, Nam K, An S, Park JS. Bai CZ, et al. Among authors: park js. Int J Pharm. 2013 Mar 10;445(1-2):79-87. doi: 10.1016/j.ijpharm.2013.01.057. Epub 2013 Feb 4. Int J Pharm. 2013. PMID: 23384727

6

Nonviral gene delivery to human ovarian cancer cells using arginine-grafted PAMAM dendrimer.

Jang SH, Choi SJ, Oh JH, Chae SW, Nam K, Park JS, Lee HJ. Jang SH, et al. Among authors: park js. Drug Dev Ind Pharm. 2011 Jan;37(1):41-6. doi: 10.3109/03639045.2010.489563. Epub 2010 Oct 15. Drug Dev Ind Pharm. 2011. PMID: 20950058

7

Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine.

Choi JS, Nam K, Park JY, Kim JB, Lee JK, Park JS. Choi JS, et al. Among authors: park jy, park js. J Control Release. 2004 Oct 19;99(3):445-56. doi: 10.1016/j.jconrel.2004.07.027. J Control Release. 2004. PMID: 15451602

8

Enhanced transfection of primary cortical cultures using arginine-grafted PAMAM dendrimer, PAMAM-Arg.

Kim JB, Choi JS, Nam K, Lee M, Park JS, Lee JK. Kim JB, et al. Among authors: park js. J Control Release. 2006 Aug 10;114(1):110-7. doi: 10.1016/j.jconrel.2006.05.011. Epub 2006 Jul 12. J Control Release. 2006. PMID: 16842881

9

A new biodegradable crosslinked polyethylene oxide sulfide (PEOS) hydrogel for controlled drug release.

Koo H, Jin GW, Kang H, Lee Y, Nam HY, Jang HS, Park JS. Koo H, et al. Among authors: park js. Int J Pharm. 2009 Jun 5;374(1-2):58-65. doi: 10.1016/j.ijpharm.2009.03.010. Epub 2009 Mar 19. Int J Pharm. 2009. PMID: 19446760

10

Neuroprotection by biodegradable PAMAM ester (e-PAM-R)-mediated HMGB1 siRNA delivery in primary cortical cultures and in the postischemic brain.

Kim ID, Lim CM, Kim JB, Nam HY, Nam K, Kim SW, Park JS, Lee JK. Kim ID, et al. Among authors: park js. J Control Release. 2010 Mar 19;142(3):422-30. doi: 10.1016/j.jconrel.2009.11.011. Epub 2009 Nov 26. J Control Release. 2010. PMID: 19944723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,363 results

Search Page

Filters